Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature

Figure 1 Radiographic response to neoadjuvant chemotherapy. A: A 70-year-old man presented with a T2-hyperintense metachronous rectal liver metastasis, seen on magnetic resonance imaging; B: Computed tomography scan performed after 6 cycles of FOLFOX plus bevacizumab showed partial Response Evaluation Criteria in Solid Tumors response with decrease in maximum diameter from 9.6 cm to 7.0 cm, as well as optimal morphologic response. The section planes displayed above show the tumor in maximum diameter. The patient subsequently underwent right posterior sectionectomy with no evidence of disease 3 yr after surgery.